Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment

W Zhou, Y Zhou, X Chen, T Ning, H Chen, Q Guo… - Biomaterials, 2021 - Elsevier
Immunotherapy has gained increasing focus in treating pancreatic ductal adenocarcinoma
(PDAC), since conventional therapies like chemotherapy could not provide satisfactory …
被引用次数：306 相关文章

Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment.

W Zhou, Y Zhou, X Chen, T Ning, H Chen, Q Guo… - Biomaterials, 2020 - europepmc.org
Immunotherapy has gained increasing focus in treating pancreatic ductal adenocarcinoma
(PDAC), since conventional therapies like chemotherapy could not provide satisfactory …

Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment

W Zhou, Y Zhou, X Chen, T Ning, H Chen… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Immunotherapy has gained increasing focus in treating pancreatic ductal adenocarcinoma
(PDAC), since conventional therapies like chemotherapy could not provide satisfactory …

[引用][C] Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment

W Zhou, Y Zhou, X Chen, T Ning, H Chen, Q Guo… - Biomaterials, 2021 - cir.nii.ac.jp
Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming
tumor microenvironment | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

[引用][C] Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment

W Zhou, Y Zhou, X Chen, T Ning, H Chen, Q Guo… - 2021